
SABS
USDSAB Biotherapeutics Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$3.140
Máximo
$3.330
Mínimo
$3.140
Volume
0.08M
Fundamentos da empresa
Capitalização de mercado
33.1M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.27M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
Ações relacionadas
EVLVW
Evolv Technologies Holdings Inc. Warrant
PFH
Prudential Financial Inc. 4.125% Junior Subordinated Notes due 2060
TCBIO
Texas Capital Bancshares Inc. Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B
MACA
Moringa Acquisition Corp Ordinary Shares
ESTC
Elastic N.V. Ordinary Shares
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.